{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T11:10:08Z","timestamp":1754046608613,"version":"3.41.2"},"reference-count":41,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016196","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T10:43:42Z","timestamp":1754045022000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scalp cooling for the prevention of chemotherapy-induced alopecia in women with early breast cancer"],"prefix":"10.1002","volume":"2025","author":[{"given":"Yasuyuki","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Breast Surgical Oncology, Department of Surgery; Showa Medical University; Tokyo Japan"},{"name":"Institute for Clinical Genetics and Genomics; Showa Medical University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Taruno","sequence":"additional","affiliation":[{"name":"Division of Breast Surgical Oncology, Department of Surgery; Showa Medical University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Tohoku University Graduate School of Medicine; Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Inoki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine; Showa Medical University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noyuri","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology; Showa Medical University; Tokyo Japan"},{"name":"Department of Family Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine; The University of Tokyo; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Noma","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Statistical Mathematics; The Institute of Statistical Mathematics; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Ota","sequence":"additional","affiliation":[{"name":"Global Health Nursing; St. Luke's International University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology; Showa Medical University; Tokyo Japan"},{"name":"Department of Hygiene, Public Health, and Preventive Medicine, Graduate School of Medicine; Showa Medical University; Tokyo Japan"},{"name":"Department of Nephrology, Graduate School of Medicine; Showa Medical University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD016196-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD016196-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ad.2021.09.003","article-title":"Chemotherapy, alopecia, and scalp cooling systems","volume":"113","author":"Amarillo","year":"2022","journal-title":"Actas Dermo-Sifiliograficas"},{"issue":"2","key":"10.1002\/14651858.CD016196-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdt476","article-title":"Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients","volume":"25","author":"Cho","year":"2014","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD016196-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pon.1245","article-title":"Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review","volume":"17","author":"Lemieux","year":"2008","journal-title":"Psycho-Oncology"},{"issue":"3","key":"10.1002\/14651858.CD016196-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/ecc.13395","article-title":"Permanent hair loss associated with taxane chemotherapy use in breast cancer: a retrospective survey at two tertiary UK cancer centres","volume":"30","author":"Chan","year":"2021","journal-title":"European Journal of Cancer Care"},{"issue":"3","key":"10.1002\/14651858.CD016196-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"10.1002\/14651858.CD016196-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e2020074","DOI":"10.5826\/dpc.1003a74","article-title":"Prevention and treatment of chemotherapy-induced alopecia","volume":"10","author":"Rossi","year":"2020","journal-title":"Dermatology Practical & Conceptual"},{"issue":"11","key":"10.1002\/14651858.CD016196-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/ijd.15812","article-title":"Post-chemotherapy alopecia: what the dermatologist needs to know","volume":"60","author":"Santos","year":"2021","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD016196-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clbc.2017.07.012","article-title":"Scalp hypothermia for preventing alopecia during chemotherapy. A systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Rugo","year":"2018","journal-title":"Clinical Breast Cancer"},{"issue":"4","key":"10.1002\/14651858.CD016196-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/0284186X.2012.658966","article-title":"Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry","volume":"51","author":"den Hurk","year":"2012","journal-title":"Acta Oncologica"},{"issue":"4","key":"10.1002\/14651858.CD016196-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4103\/apjon.apjon_19_19","article-title":"Improving information provision on chemotherapy induced alopecia and scalp cooling: a comprehensive approach including a website and web-based decision tool","volume":"6","author":"den Hurk","year":"2019","journal-title":"Asia-Pacific Journal of Oncology Nursing"},{"issue":"6","key":"10.1002\/14651858.CD016196-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD016196-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD016196-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00365518509155250","article-title":"Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man","volume":"45","author":"Bulow","year":"1985","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"2","key":"10.1002\/14651858.CD016196-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10549-011-1453-y","article-title":"Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up","volume":"128","author":"Lemieux","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD016196-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-014-3231-0","article-title":"No effect of scalp cooling on survival among women with breast cancer","volume":"149","author":"Lemieux","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD016196-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/ neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD016196-BIB0018|cit18","first-page":"A2134","article-title":"Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur","volume":"154","author":"de Sande","year":"2010","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"4","key":"10.1002\/14651858.CD016196-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NCC.0000000000001234","article-title":"Effectiveness of scalp cooling to prevent chemotherapy-induced alopecia in patients undergoing breast cancer treatment: a systematic review and meta-analysis","volume":"47","author":"Molina","year":"2024","journal-title":"Cancer Nursing"},{"issue":"16","key":"10.1002\/14651858.CD016196-BIB0020|cit20","first-page":"5090","article-title":"Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis","volume":"25","author":"Shen","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD016196-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"E442","DOI":"10.1002\/ijc.29115","article-title":"Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis","volume":"136","author":"Shin","year":"2015","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD016196-BIB0022|cit22","volume-title":"Clinical Guideline for Appearance Care in Cancer Treatment","author":"Japanese Association for Supportive Care in Cancer (JASCC)","year":"2021"},{"key":"10.1002\/14651858.CD016196-BIB0023|cit23","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) \u2013 Breast Cancer (version 4.2025) https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1419"},{"issue":"2","key":"10.1002\/14651858.CD016196-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","article-title":"Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines","volume":"32","author":"Lacouture","year":"2021","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD016196-BIB0025|cit25","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD016196-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD016196-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"26","key":"10.1002\/14651858.CD016196-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM197912273012605","article-title":"Prevention of doxorubicin-induced hair loss with scalp hypothermia","volume":"301","author":"Dean","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD016196-BIB0029|cit29","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD016196-BIB0030|cit30","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD016196-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016196-BIB0032|cit32","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0033|cit33","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0034|cit34","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022) Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD016196-BIB0035|cit35","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD016196-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/ije\/dyu080","article-title":"What is the difference between missing completely at random and missing at random?","volume":"43","author":"Bhaskaran","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD016196-BIB0037|cit37","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0038|cit38","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0039|cit39","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0040|cit40","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024), Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016196-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.breast.2016.09.007","article-title":"Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature","volume":"30","author":"Komen","year":"2016","journal-title":"Breast"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T10:43:47Z","timestamp":1754045027000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016196"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016196","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}